ABT vs DEVS
Abbott Laboratories (ABT) versus DevvStream Corp. Common Stock (DEVS) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. DEVS currently screens at market cap $13.4M.
Not investment advice. Open the ABT and DEVS stock pages for the full models.
Not investment advice.